Kluyveromyces marxianus engineering bacterium for efficiently synthesizing inositol and application thereof

By knocking out specific genes in the Maxkluveryces strain and introducing inositol synthetase gene, the Maxkluveryces metabolic engineering strain that efficiently synthesizes inositol was solved, and the problem of low inositol production in Pichia yeast was achieved. Highly efficient inositol production and safety improvement.

CN118931747APending Publication Date: 2024-11-12FUDAN UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410896745.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-05
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The yield of inositol in the existing biofermentation method is lower than that of Pichia cerevisiae, and the microbial host of the biofermentation method has not been fully explored, resulting in the limitation of inositol production efficiency and safety.

Method used

CRISPR gene editing technology knocked out specific genes in the Max Kluvia strain, and inositol phosphate synthase TbIPS and inositol monophosphatase EcIMP gene were introduced to construct a Max Kluvia metabolic engineering strain that efficiently synthesizes inositol. The expression plasmid was constructed using the inulinase promoter and TEF terminator to achieve co-expression of inositol phosphate synthase and inositol monophosphatase.

Benefits of technology

The yield of inositol was significantly improved, reaching 29.1g/L-80.65g/L, achieving efficient use of glucose to synthesize inositol, with wide application prospects and good production efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118931747A_ABST
    Figure CN118931747A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of bioengineering, and particularly relates to kluyveromyces marxianus engineering bacteria for efficiently synthesizing inositol and application of the kluyveromyces marxianus engineering bacteria. According to the kluyveromyces marxianus engineering bacterium for efficiently synthesizing the inositol, disclosed by the invention, a glucose-6-phosphate isomerase PGI gene, a glucose-6-phosphate dehydrogenase ZWF1 gene, an inositol oxygenase MIOX5 gene and an inositol transporter protein ITR2 gene are sequentially knocked out from a kluyveromyces marxianus FIM1 delta ura3 strain; and transferring into a carrier pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu which is used for co-expressing a trypanosoma buchneri inositol phosphate synthase TbIPS gene and an escherichia coli inositol monophosphate enzyme EcIMP gene, so as to obtain the trypanosoma buchneri inositol phosphate synthase-Tinu-EcIMP-Ttef-TbIPS-Tinu gene. The invention further discloses a method for efficiently preparing the inositol, namely, the kluyveromyces marxianus engineering strain is used as a fermentation strain, glucose, glycerol, a yeast extract, peptone and other components are used as a culture medium, the inositol is produced through culture and fermentation, and the yield of the inositol in supernatant can reach 80.65 g / L.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of bioengineering, and in particular relates to an engineering bacterium of Kluyveromyces marxianus for synthesizing inositol and an application thereof. Background Art

[0002] Inositol was first isolated from muscle extracts in 1850 (Bizzarri et al., Eur Rev Med Pharmacol Sci. 2014, 18: 1896-1903) and has multiple functions in organisms (Michell et al., Biochem Soc Symp. 2007, 74: 223-46). It has attracted the attention of clinicians in the past two decades (Dinicola et al., Int J Mol Sci, 2021, 22: 10575). Various studies have shown that inositol or its derivatives can affect embryonic development, insulin signaling, stress response, etc. (Thomas et al., Angew Chem Int Ed, 2016, 55: 1614). The human body has its own endogenous inositol synthesis pathway. Endogenous inositol can be synthesized through glucose-6-phosphate, which is isomorphized into inositol-3-phosphate by inositol-3-phosphate synthase (Inositol1-phosphate synthase, IPS) (Wong et al., Neurochem, 1987, 48: 1434-1442), and then dephosphorylated by inositol monophosphatase (Inositolmonophosphatase, IMP) to form inositol (Loewus et al., J Biol Chem. 1980, 255: 11710-11712.). However, it is still necessary to take about 1g of inositol from cereals, beans, and nuts through diet every day (Dinicola et al., S Int J Mol Sci, 2017, 18: 2187.), especially when the endogenous inositol in the human body is not enough to meet the physiological needs of the human body. Based on the needs and multiple functions of the human body, inositol is widely used in food, feed, medicine, cosmetics, industry and other fields.

[0003] Inositol production can be divided into chemical acid hydrolysis, in vitro enzyme synthesis, and biological fermentation. Chemical acid hydrolysis mainly uses phytate as raw material, and extracts inositol by pressurized acid hydrolysis (Li et al., Biotechnol Appl Biochem. 2022, 69: 1101-1111), but a large amount of chemical waste liquid will be produced in the process, and the steps are relatively cumbersome. The method of in vitro enzyme synthesis can combine purified enzymes and coenzymes from different sources to achieve a one-pot biological cascade reaction (You et al., Process Biochem. 2017, 52: 106-14), and the process is controllable, the yield is high, and the product is easy to separate. Compared with the chemical acid hydrolysis method, it has significant advantages, but compared with the biological fermentation method, the production cost of the enzyme is high, and the enzyme is also unstable. The biological fermentation method produces inositol through different microbial hosts, which has the advantage of green sustainability. In recent years, the representative hosts for the production of inositol by biological fermentation are mainly Escherichia coli (You et al., Microb Cell Fact. 2020, 19: 109) and Pichia pastoris (Zhang et al., Microb Cell Fact. 2022, 21: 112). High titers can be achieved in Escherichia coli, but it is not a food-safe strain, which limits its application prospects. The inositol titer in Pichia pastoris is significantly lower than that in Escherichia coli, so there is still room for further exploration and improvement of microbial hosts for the production of inositol by biological fermentation.

[0004] Kluyveromyces marxianus is an unconventional yeast and the fastest growing yeast known so far (Groeneveld et al., FEBS J, 2009, 27: 254-270). It has high temperature tolerance (Lane et al., Anton Leeuw Int JG, 2011, 100: 507-519), can utilize multiple carbon sources such as inulin, xylose, and lactose (Fonseca et al., Appl Microbiol Bioechnol, 2008, 79(3): 339-354), is a GRAS organism, has obtained QPS certification, and has been recognized by the Ministry of Health of my country as a food safety strain (Wu et al., J Biotechnol, 2020, 320: 11-16). The whole genome was sequenced in 2012 (Jeong et al., Eukaryotic Cell, 2012, 11: 1584-1585). The physiological and metabolic properties of K. marxianus make it a promising candidate for a wide range of biotechnological applications. As a broadly Crabtree-negative yeast, it prefers respiration rather than fermentation, thus eliminating the need to divert ethanol metabolism away from the yeast. Wild-type yeast has been used to produce aroma compounds, and it can produce more than 2 g L -1 h-1 2017 Development of gene editing tools for Kluyveromyces marxianus ( et al., Biotechnol Biofuels, 2017, 10: 164) which provides the basis for multi-dimensional and complex genetic and metabolic modifications, thus gradually being used to produce proteins and various products with economic value. Summary of the invention

[0005] The invention aims to provide a metabolic engineering strain of Kluyveromyces marxianus for efficiently synthesizing inositol and application thereof.

[0006] The metabolic engineering strain of Kluyveromyces marxianus for efficiently synthesizing inositol provided by the present invention is constructed by the following steps:

[0007] (1) Using Crispr gene editing technology, the glucose-6-phosphate isomerase PGI gene (Genbank accession number: QGN13438.1) and glucose-6-phosphate dehydrogenase ZWF1 gene (Genbank accession number: QGN16990.1) in the genome of Kluyveromyces marxianus FIM1Δura3 strain were knocked out to construct a Kluyveromyces marxianus strain named FIM1Δura3ΔpgiΔzwf1;

[0008] (2) The inositol oxygenase MIOX5 gene (Genbank accession number: QGN14246.1) was knocked out in the Kluyveromyces marxianus strain FIM1Δura3ΔpgiΔzwf1 to construct a Kluyveromyces marxianus chassis strain, denoted as FIM1Δura3ΔpgiΔzwf1Δmiox5;

[0009] (3) The inositol transporter ITR2 gene (Genbank accession number: QGN17849.1) was knocked out in the Kluyveromyces marxianus chassis strain FIM1Δura3ΔpgiΔzwf1Δmiox5 to construct a Kluyveromyces marxianus chassis strain named FIM1Δura3ΔpgiΔzwf1Δmiox5Δitr2;

[0010] (4) Using the inulinase promoter Pinu and the TEF terminator Ttef, the Trypanosoma brucei inositol phosphate synthase TbIPS gene expression cassette was constructed; using the TEF promoter Ptef and the inulinase terminator Tinu, the Escherichia coli gene inositol monophosphatase EcIMP gene expression cassette was constructed; the TbIPS gene expression cassette and the EcIMP gene expression cassette were sequentially inserted into a Kluyveromyces marxianus expression vector pUKDN115 to construct a co-expression plasmid of inositol phosphate synthase TbIPS and inositol monophosphatase EcIMP, which was recorded as pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu;

[0011] (5) The constructed expression plasmid pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu was transformed into the Kluyveromyces marxianus strain FIM1Δura3ΔpgiΔzwf1Δmiox5 described in step (2) or the Kluyveromyces marxianus strain FIM1Δura3ΔpgiΔzwf1Δmiox5Δitr2 described in step (3); and the following were obtained by screening:

[0012] The engineered Kluyveromyces marxianus strain FIM1Δura3ΔpgiΔzwf1Δmiox5 / pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu was named Kluyveromyces marxianus JC-3;

[0013] The engineered Kluyveromyces marxianus strain FIM1Δura3ΔpgiΔzwf1Δmiox5Δitr2 / pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu was named Kluyveromyces marxianus JC-4.

[0014] The Kluyveromyces marxianus FIM1Δura3 strain is obtained by knocking out the uracil synthase gene URA3 on the genome of the Kluyveromyces marxianus FIM1 strain (accession number: CGMCC No. 10621) deposited in the China General Microbiological Culture Collection Center.

[0015] The Kluyveromyces marxianus expression vector pUKDN115 described in step (3) contains Kluyveromyces marxianus autonomous replication sequence, inulinase promoter, inulinase terminator and selection marker gene URA3 and other elements.

[0016] In the Kluyveromyces marxianus strain FIM1Δura3, the glucose-6-phosphate isomerase PGI gene was knocked out, the purpose of which was to block the isomerization of glucose-6-phosphate to fructose-6-phosphate in the cell, thereby entering the EMP pathway (Embden-Meyerhof-Parnas pathway).

[0017] In the Kluyveromyces marxianus strain FIM1Δura3, the glucose-6-phosphate dehydrogenase ZWF1 gene was knocked out, the purpose of which was to block the intracellular oxidation of glucose-6-phosphate to 6-phosphogluconate, thereby entering the pentose phosphate pathway.

[0018] Furthermore, the inositol oxygenase MIOX5 gene was knocked out in the Kluyveromyces marxianus FIM1Δura3ΔpgiΔzwf1 strain in order to prevent the generated inositol from being oxidatively degraded.

[0019] In the Kluyveromyces marxianus FIM1Δura3ΔpgiΔzwf1 strain, the inositol transporter ITR2 gene was knocked out to block the transport of inositol into the cell for metabolic utilization.

[0020] In order to synthesize inositol in Kluyveromyces marxianus cells, the present invention provides a method for co-expressing inositol phosphate synthase TbIPS and inositol monophosphatase EcIMP, comprising: constructing a TbIPS gene expression frame and an EcIMP gene expression frame in series on a pUKDN115 vector, and then introducing them into Kluyveromyces marxianus.

[0021] The nucleotide sequence of the inositol phosphate synthase TbIPS is shown in SEQ ID No.1, and the amino acid sequence is shown in SEQ ID No.2.

[0022] The inositol monophosphatase EcIMP has a nucleotide sequence as shown in SEQ ID No.3 and an amino acid sequence as shown in SEQ ID No.4.

[0023] The present invention also provides a method for efficiently synthesizing inositol using the above-mentioned Kluyveromyces marxianus metabolic engineering strain (including Kluyveromyces marxianus JC-3 and JC-4), specifically, using the Kluyveromyces marxianus metabolic engineering strain as a fermentation strain, using glucose, glycerol, yeast extract, peptone and other ingredients as a culture medium, and producing inositol through culture and fermentation.

[0024] The specific operation is as follows: inoculate Kluyveromyces marxianus JC-3 or JC-4 into 50 mL of YPD medium containing 2% glycerol, and continuously culture at 30°C and 220 rpm for 168 hours. Among them, add 1 mL of 50% glycerol when the culture reaches 96 hours, and add 1 mL of 50% glucose every 24 hours. Ferment for 144 hours to 168 hours to obtain high-yield inositol: 29.1 g / L-38.9 g / L.

[0025] Specifically, after 144 hours of fermentation, the inositol production reached 29.1 g / L, and after 168 hours of fermentation, the inositol production was 38.9 g / L.

[0026] A preferred method is to inoculate Kluyveromyces marxianus JC-3 or JC-4 in a YPD medium containing 2% glycerol at a seed amount of 10% into a fermenter containing a YPD medium containing 2% glycerol, feed 50% glucose as the first carbon source, and feed 50% glycerol as the second carbon source, and perform continuous fed-batch fermentation. Under the conditions of continuous fed-batch fermentation, the strain is fermented at a high density for 168-192 hours to obtain a high yield of inositol: 59.68 g / L-80.65 g / L.

[0027] Specifically, after 168 hours of high-density fermentation, the inositol production can reach 59.68 g / L, and the sugar alcohol conversion rate can reach 56.65%; after 192 hours of high-density fermentation, the inositol production can reach 80.65 g / L.

[0028] The Kluyveromyces marxianus engineered strain provided by the present invention can efficiently utilize glucose to synthesize inositol, has broad application prospects, can realize large-scale fermentation production of inositol, has significant advantages in yield, and has good application value. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 Metabolic modification roadmap for engineering bacteria to synthesize inositol in Kluyveromyces marxianus.

[0030] Figure 2 This is the plasmid map for recombinant co-expression of inositol synthase TbIPS and EcIMP in Kluyveromyces marxianus.

[0031] Figure 3 Growth curves (a) and inositol production curves (b) of the constructed Kluyveromyces marxianus engineered strains JC-1, JC-2 and JC-3 for synthesizing inositol in shake flasks in YPD containing 5% glucose and 2% glycerol, respectively.

[0032] Figure 4 Growth curves (a) and inositol production curves (b) of the constructed Kluyveromyces marxianus engineered strains JC-3 and JC-4 for synthesizing inositol in shake flask fermentation in YPD containing 2% glucose and 2% glycerol.

[0033] Figure 5 The bacterial growth and inositol production of the engineered strain JC-4 of Kluyveromyces marxianus in a continuous fed-batch fermentation tank. DETAILED DESCRIPTION

[0034] Example 1, Construction of Kluyveromyces marxianus FIM1Δura3Δpgi strain

[0035] In the synthesis process of inositol, glucose-6-phosphate generates inositol phosphate under the catalysis of inositol phosphate synthase IPS, and then inositol monophosphatase IMP catalyzes phosphate hydrolysis to generate inositol. In order to improve the synthesis efficiency of inositol in Kluyveromyces marxianus, it is necessary to block the downstream metabolism of glucose-6-phosphate in the glycolysis pathway of Kluyveromyces marxianus and guide the glucose metabolic flow into the inositol synthesis pathway. Glucose-6-phosphate isomerase (PGI) is a key enzyme in glycolysis that converts glucose-6-phosphate into fructose-6-phosphate. Therefore, the present invention uses CRISPR Cas9 gene editing technology to knock out the glucose-6-phosphate isomerase gene PGI of Kluyveromyces marxianus FIM1Δura3 strain. And synthesize gRNA primers PGIg-F (tcatggcaactgagttgtccgca) and PGIg-R (aactgcggacaactcagttgcca), and gRNA targets the 35-55bp position of the PGI cds region. The gRNA plasmid and donor sequence required for knocking out the PGI gene were constructed, where the Donor sequence consisted of 500 bp upstream and downstream of the PGI gene cds region, totaling 1000 bp. The gRNA plasmid and donor sequence were simultaneously transformed into the FIM1Δura3 strain, and clones with successful knockout of the PGI gene were obtained through uracil-deficient plate screening and PCR verification. The strain that lost the gRNA plasmid was then screened on a 5-fluoroorotic acid plate to obtain the strain FIM1Δura3Δpgi.

[0036] Example 2: Construction of Kluyveromyces marxianus FIM1Δura3ΔpgiΔzwf1 strain

[0037] Based on the strain FIM1Δura3Δpgi, the glucose-6-phosphate dehydrogenase ZWF1 gene was further knocked out. The gRNA plasmid and donor sequence required for knocking out the ZWF1 gene were first constructed using basic molecular cloning technology. The gRNA primers were ZWF1g-F (tcatttggtacagaaggccgcgg) and ZWF1g-R (aacccgcggccttctgtaccaaa) targeting the 667-687bp position of the ZWF1 cds region. The donor sequence consisted of 500bp upstream and downstream of the ZWF1 gene cds region. At the same time, the gRNA plasmid and donor sequence were simultaneously transformed into the FIM1Δura3Δpgi strain, and clones with successful knockout of the ZWF1 gene were obtained through uracil deficiency plate screening and PCR verification. The strains that lost the gRNA plasmid were then screened on 5-fluoroorotic acid plates. Since the glucose metabolism of Kluyveromyces marxianus was theoretically completely blocked after the PGI and ZWF1 genes were knocked out at the same time, glycerol with a final concentration of 2% was required as the second carbon source to maintain cell growth during screening and subsequent culture. The Kluyveromyces marxianus strain FIM1Δura3ΔpgiΔzwf1 was obtained.

[0038] Example 3: Construction of Kluyveromyces marxianus FIM1Δura3ΔpgiΔzwf1Δmiox5 strain

[0039] The FIM1Δura3ΔpgiΔzwf1 strain has blocked the downstream shunt of glucose-6-phosphate, further blocking the downstream decomposition pathway of inositol. The inositol oxygenase MIOX5 gene was further knocked out based on the FIM1Δura3ΔpgiΔzwf1 strain. The gRNA plasmid and donor sequence required for knocking out the MIOX5 gene were first constructed using basic molecular cloning technology. The gRNA primers are as follows: MOIX5g-F: TCAagtcattattcatagtgata; MIOX5g-R: AACtatcactatgaataatgact, targeting the 66-86bp position of the MIOX5 gene cds region. The donor sequence consists of 500bp upstream and downstream of the MIOX5 gene cds region, totaling 1000bp. At the same time, the gRNA plasmid and donor sequence were transformed into the FIM1Δura3ΔpgiΔzwf1 strain. The clones with successful knockout of miox5 were obtained by uracil-deficient plate screening and PCR verification. The strains that lost the gRNA plasmid were then screened on 5-fluoroorotic acid plates to obtain the strain FIM1Δura3ΔpgiΔzwf1Δmiox5.

[0040] Example 4: Construction of Kluyveromyces marxianus FIM1Δura3ΔpgiΔzwf1Δmiox5Δitr2 strain

[0041] The FIM1Δura3ΔpgiΔzwf1Δmiox5 strain has blocked the downstream shunt of glucose-6-phosphate and the downstream decomposition pathway of inositol. The transport pathway for transporting inositol into the cell is further blocked to prevent the cell from transporting inositol in the system into the cell for use. Therefore, based on the FIM1Δura3ΔpgiΔzwf1Δmiox5 strain, the inositol transporter ITR2 gene was further knocked out. The gRNA plasmid and donor sequence required for knocking out ITR2 were first constructed by basic molecular cloning technology. The gRNA primers are as follows: ITR2g-F: TCAggttgctggtagactagtta; ITR2g-R: AACtaactagtctaccagcaacc, targeting the 480-500bp position of the ITR2 gene cds region. The Donor sequence consists of 500bp upstream and downstream of the ITR2 gene cds region. At the same time, the gRNA plasmid and donor sequence were transformed into the FIM1Δura3ΔpgiΔzwf1Δmiox5 strain. The clones with successful knockout of the ITR2 gene were obtained by uracil-deficient plate screening and PCR verification. The strains that lost the gRNA plasmid were then screened on 5-fluoroorotic acid plates to obtain the strain FIM1Δura3ΔpgiΔzwf1Δmiox5Δitr2.

[0042] Example 5, Construction of Kluyveromyces marxianus inositol synthesis pathway strain

[0043] The inositol phosphate synthase TbIPS and inositol monophosphatase EcIMP required for inositol synthesis are derived from Trypanosoma brucei and Escherichia coli, respectively. Codon optimization and synthesis are performed without changing the amino acid sequence. TbIPS and EcIMP fragments can be obtained by PCR amplification. Since TbIPS and EcIMP need to be expressed simultaneously, two sets of expression elements are required to regulate the expression of TbIPS and EcIMP respectively. TEF promoter TEFpr ​​and TEF terminator TEFt are obtained by PCR amplification from the plasmid preserved in the laboratory. Through overlap PCR technology, the four fragments of TEFt, TEFpr, EcIMP, and TbIPS are fused into the fragment EcIMP-TEFt-TEFpr-TbIPS, and the fusion fragment is inserted into the Kluyveromyces marxianus expression vector pUKDN115 for expression, obtaining the plasmid pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu.

[0044] The constructed pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu plasmid was transformed into Kluyveromyces marxianus chassis cells FIM1Δura3Δpgi, FIM1Δura3ΔpgiΔzwf1, FIM1Δura3ΔpgiΔzwf1Δmiox5, and FIM1Δura3ΔpgiΔzwf1Δmiox5Δitr2, respectively, to obtain Kluyveromyces marxianus engineered bacteria FIM1Δura3Δpgi / pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu, named JC-1; the Kluyveromyces marxianus engineered bacteria FIM1Δura3Δpgi / pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu was named JC-1; 1Δura3ΔpgiΔzwf1 / pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu, named JC-2; the engineered strain of Kluyveromyces marxianus FIM1Δura3ΔpgiΔzwf1Δmiox5 / pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu, named JC-3; the engineered strain of Kluyveromyces marxianus FIM1Δura3ΔpgiΔzwf1Δmiox5Δitr2 / pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu, named JC-4.

[0045] Example 6, inositol production by shaking flask fermentation of JC-1, JC-2, and JC-3

[0046] Strains JC-1, JC-2, and JC-3 were streaked on YPD plates containing 2% glycerol and activated overnight at 30°C. 3-5 single clones were picked and inoculated into 50 mL of YPD medium containing 5% glucose and 2% glycerol, and cultured at 30°C and 220 rpm for 168 h. Samples were taken every 24 h to record the cell density and inositol production. The results showed that ( Figure 3 ), fermented to 168h, the cell densities of JC-1, JC-2 and JC-3 were OD 600 =46.51,OD 600 =44.32,OD 600 =44.68. The inositol yields of JC-1, JC-2, and JC-3 were 8.23 ​​g / L, 11.57 g / L, and 14.68 g / L, respectively. The inositol yield of JC-2 increased by 40.5% compared to JC-1, and that of JC-3 increased by 26.9% compared to JC-2.

[0047] Example 7 Production of inositol by shake flask fermentation of Kluyveromyces marxianus JC-4

[0048] Streak the Kluyveromyces marxianus strains JC-3 and JC-4 on YPD plates containing 2% glycerol and activate them overnight at 30°C. Pick 3-5 single clones and inoculate them into 50mL YPD medium containing 2% glucose and 2% glycerol, and culture them at 30°C and 220rpm for 168h. Add 1mL of 50% glycerol when the culture reaches 96h, and add 1mL of 50% glucose every 24h until 144h. The results show that ( Figure 4 ), after reducing the initial glucose, the cell density of JC-3 was OD 600 =89, inositol production 29.1g / L, compared with 5% glucose and 2% glycerol YPD medium increased by 98.2%. JC-4 strain fermented to 168h, the cell density was OD 600 =103, inositol production was 38.9 g / L, which was 33.9% higher than that of JC-3.

[0049] Example 8 Continuous fed-batch fermentation of Kluyveromyces marxianus JC-4 to produce inositol

[0050] Streak strain JC-4 on a YPD plate containing 2% glycerol and activate overnight at 30°C. Pick 3-5 single clones and inoculate them into 150mL YPD medium containing 2% glycerol and culture for 48h. Inoculate strain JC-4 into a fermenter containing 2% glycerol YPD medium with an initial inoculation amount of 10%, add 50% glucose as the first carbon source, and add 50% glycerol as the second carbon source for continuous fed-batch fermentation. The dissolved oxygen was maintained at a constant 30% during the process, the glycerol concentration of the system was 1%-3%, and the glucose concentration was 1%-2%. The results showed that ( Figure 5 ), at 168h of fermentation, the inositol production of JC-4 was 59.68g / L; at 192h of fermentation, the inositol production was 80.65g / L, and the sugar alcohol conversion rate was about 56.65%.

Claims

1. A metabolically engineered strain of Kluyveromyces marxianus for efficiently synthesizing inositol, characterized in that: It is constructed by the following steps: (1) Using Crispr gene editing technology, the glucose-6-phosphate isomerase PGI gene and the glucose-6-phosphate dehydrogenase ZWF1 gene in the genome of Kluyveromyces marxianus FIM1Δura3 strain were knocked out to construct a Kluyveromyces marxianus strain, which was named FIM1Δura3ΔpgiΔzwf1; (2) The inositol oxygenase MIOX5 gene was knocked out in the Kluyveromyces marxianus strain FIM1Δura3ΔpgiΔzwf1 to construct a Kluyveromyces marxianus chassis strain, denoted as FIM1Δura3ΔpgiΔzwf1Δmiox5; (3) The inositol transporter ITR2 gene was knocked out in the Kluyveromyces marxianus chassis strain FIM1Δura3ΔpgiΔzwf1Δmiox5 to construct a Kluyveromyces marxianus chassis strain, which was named FIM1Δura3ΔpgiΔzwf1Δmiox5Δitr2; (4) Using the inulinase promoter Pinu and the TEF terminator Ttef, the Trypanosoma brucei inositol phosphate synthase TbIPS gene expression cassette was constructed; using the TEF promoter Ptef and the inulinase terminator Tinu, the Escherichia coli gene inositol monophosphatase EcIMP gene expression cassette was constructed; the TbIPS gene expression cassette and the EcIMP gene expression cassette were sequentially inserted into a Kluyveromyces marxianus expression vector pUKDN115 to construct a co-expression plasmid of inositol phosphate synthase TbIPS and inositol monophosphatase EcIMP, which was recorded as pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu; (5) The constructed expression plasmid pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu was transformed into the Kluyveromyces marxianus strain FIM1Δura3ΔpgiΔzwf1Δmiox5 described in step (2) or the Kluyveromyces marxianus strain FIM1Δura3ΔpgiΔzwf1Δmiox5Δitr2 described in step (3); and the following were obtained by screening: The engineered Kluyveromyces marxianus strain FIM1Δura3ΔpgiΔzwf1Δmiox5 / pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu was named Kluyveromyces marxianus JC-3; The engineered Kluyveromyces marxianus strain FIM1Δura3ΔpgiΔzwf1Δmiox5Δitr2 / pUKDN115-Pinu-EcIMP-Ttef-Ptef-TbIPS-Tinu was named Kluyveromyces marxianus JC-4; in: The Kluyveromyces marxianus expression vector pUKDN115 contains a Kluyveromyces marxianus autonomous replication sequence, an inulinase promoter, an inulinase terminator and a selection marker gene URA3 element; The Kluyveromyces marxianus FIM1Δura3 strain is obtained by knocking out the uracil synthase gene URA3 on the genome of the Kluyveromyces marxianus FIM1 strain, which is deposited in the China General Microbiological Culture Collection Center and has a deposit number of CGMCC No.10621. The glucose-6-phosphate isomerase PGI gene, Genbank accession number: QGN13438.1; the glucose-6-phosphate dehydrogenase ZWF1 gene, Genbank accession number: QGN16990.1; the inositol oxygenase MIOX5 gene, Genbank accession number: QGN14246.1; the inositol transporter ITR2 gene, Genbank accession number: QGN17849.1; The nucleotide sequence of the inositol phosphate synthase TbIPS is shown in SEQ ID No.1, and the amino acid sequence is shown in SEQ ID No.2; the nucleotide sequence of the inositol monophosphatase EcIMP is shown in SEQ ID No.3, and the amino acid sequence is shown in SEQ ID No.

4.

2. A method for synthesizing inositol using the metabolically engineered strain of Kluyveromyces marxianus according to claim 1, characterized in that: The metabolically engineered strain of Kluyveromyces marxianus is used as a fermentation strain, and glucose, glycerol, yeast extract and peptone components are used as a culture medium to produce inositol through culture and fermentation.

3. The method for synthesizing inositol according to claim 2, characterized in that, The specific operation is as follows: the metabolically engineered strain of Kluyveromyces marxianus is inoculated into 50 mL of YPD medium containing 2% glycerol, and cultured at 30°C and 220 rpm for 168 hours; and 1 mL of 50% glycerol is added when the culture reaches 96 hours, and 1 mL of 50% glucose is added every 24 hours when the culture reaches 96 hours, and fermented for 144 hours to 168 hours to obtain high-yield inositol.

4. The method for synthesizing inositol according to claim 2, characterized in that The specific operation is as follows: inoculate the metabolically engineered strain of Kluyveromyces marxianus in YPD medium containing 2% glycerol, inoculate 10% of the seed amount into a fermenter containing YPD medium with 2% glycerol, feed 50% glucose as the first carbon source, and feed 50% glycerol as the second carbon source, and perform continuous fed-batch fermentation. Under the conditions of continuous fed-batch fermentation, the strain is fermented at a high density for 168h-192h to obtain high-yield inositol.